GB202012967D0 - Compostions and methods relating to the treatment of diseases - Google Patents
Compostions and methods relating to the treatment of diseasesInfo
- Publication number
- GB202012967D0 GB202012967D0 GBGB2012967.2A GB202012967A GB202012967D0 GB 202012967 D0 GB202012967 D0 GB 202012967D0 GB 202012967 A GB202012967 A GB 202012967A GB 202012967 D0 GB202012967 D0 GB 202012967D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- compostions
- diseases
- treatment
- methods relating
- relating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (13)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2012967.2A GB202012967D0 (en) | 2020-08-19 | 2020-08-19 | Compostions and methods relating to the treatment of diseases |
CA3170629A CA3170629A1 (en) | 2020-03-16 | 2021-03-16 | Hybrid interferons for treating viral infections |
HRP20240949TT HRP20240949T1 (en) | 2020-03-16 | 2021-03-16 | Hybrid interferons for treating viral infections |
ES21711947T ES2982915T3 (en) | 2020-03-16 | 2021-03-16 | Hybrid interferons for treating viral infections |
JP2022552669A JP2023517525A (en) | 2020-03-16 | 2021-03-16 | Hybrid interferon for treating viral infections |
PL21711947.8T PL4121092T3 (en) | 2020-03-16 | 2021-03-16 | Hybrid interferons for treating viral infections |
HUE21711947A HUE067223T2 (en) | 2020-03-16 | 2021-03-16 | Hybrid interferons for treating viral infections |
EP21711947.8A EP4121092B1 (en) | 2020-03-16 | 2021-03-16 | Hybrid interferons for treating viral infections |
US17/906,569 US20230203120A1 (en) | 2020-03-16 | 2021-03-16 | Hybrid interferons for treating viral infections |
PCT/GB2021/050649 WO2021186162A1 (en) | 2020-03-16 | 2021-03-16 | Hybrid interferons for treating viral infections |
KR1020227034755A KR20230020943A (en) | 2020-03-16 | 2021-03-16 | Hybrid interferons for the treatment of viral infections |
AU2021238925A AU2021238925A1 (en) | 2020-03-16 | 2021-03-16 | Hybrid interferons for treating viral infections |
CN202180021884.7A CN115697377A (en) | 2020-03-16 | 2021-03-16 | Compositions and methods relating to the treatment of disease |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2012967.2A GB202012967D0 (en) | 2020-08-19 | 2020-08-19 | Compostions and methods relating to the treatment of diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
GB202012967D0 true GB202012967D0 (en) | 2020-09-30 |
Family
ID=72615283
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB2012967.2A Ceased GB202012967D0 (en) | 2020-03-16 | 2020-08-19 | Compostions and methods relating to the treatment of diseases |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB202012967D0 (en) |
-
2020
- 2020-08-19 GB GBGB2012967.2A patent/GB202012967D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3920923A4 (en) | Therapeutic agents and methods of treatment | |
IL288214A (en) | Quinazolin-4-one derivatives useful for the treatment of braf-associated diseases and disorders | |
IL287796A (en) | Compositions and methods for the treatment of atpase-mediated diseases | |
EP4093393A4 (en) | Compositions and methods for treatment of inflammatory conditions and diseases of the skin | |
IL286636A (en) | Compositions and methods for the treatment of kras associated diseases or disorders | |
ZA202006234B (en) | Compositions and methods for the treatment of neurological diseases | |
EP4054713A4 (en) | Compositions and methods for treatment or prevention of skin diseases and disorders with lekti | |
EP2473037A4 (en) | Method of treatment of neurodegenerative or neuro-muscular degenerative diseases and therapeutic agent to treat the same | |
IL287802A (en) | Compositions and methods for treatment of ocular diseases | |
IL290891A (en) | Compositions and methods of treating vascular diseases | |
EP4090658A4 (en) | Therapeutic agents and methods of treatment | |
EP3735248A4 (en) | Process to inhibit or eliminate eosinophilic diseases of the airway and related conditions | |
IL309317A (en) | Treatment of mtres1 related diseases and disorders | |
GB201710822D0 (en) | Methods and medical uses relating to the treatment of hypoglycaemia | |
EP4248212A4 (en) | Methods of treating diseases and disorders | |
EP4138852A4 (en) | Compositions and methods for the treatment of pain | |
GB202017244D0 (en) | Methods to extend health-span and treat age-related diseases | |
PT3937948T (en) | Phytoecdysones and the derivatives thereof for use in the treatment of neuromuscular diseases | |
GB202012967D0 (en) | Compostions and methods relating to the treatment of diseases | |
EP4225311A4 (en) | Treatment of skin diseases | |
EP4238567A4 (en) | Novel treatment and prevention of sarcopenia-related diseases | |
PL4188420T3 (en) | Compositions and methods relating to the treatment of diseases | |
GB202011945D0 (en) | Compositions and methods relating to the treatment of diseases | |
GB202003812D0 (en) | Compositions and methods relating to the treatment of diseases | |
GB202003595D0 (en) | Compositions and methods relating to the treatment of diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |